CD96 expression on leukemia stem cells in 69 children with acute leukemia

Chinese Journal of Contemporary Pediatrics

Volumn 15, Issue 8, 2013, Pages 633-637

  Wang, Xue Mei ^a   Yan, Mei ^a   Liu, Yu ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Acute leukemia; CD96; Child; Leukemia stem cell

Indexed keywords

CD123 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD96 ANTIGEN; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CELL CULTURE; FLOW CYTOMETRY; HUMAN; KARYOTYPE; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; STEM CELL;

ADOLESCENT; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; NEOPLASTIC STEM CELLS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS;

EID: 84885045211     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: 10.7499/j.issn.1008-8830.2013.08.008     Document Type: Article

References (16)

1. Cox CV, Evely RS, Oakhill A, Pamphilon DH, Goulden NJ, Blair A, et al. Characterization of acute lymphoblastic leukemia progenitor cells[J]. Blood, 2004, 104(9): 2919-2925.
2. Hosen N, Park CY, Tatsumi N, Oji Y, Suqiyama H, Gramatzki M, et al. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia[J]. Proc Natl Acad Sci USA, 2007, 104(26): 11008-11013.
3. Kaspers GJ, Zwaan CM. Pediatric acute myeloid leukemia: towards high-quality cure all patients[J]. Haematologica, 2007, 92(11): 1519-1523.
4. Maloney K, McGavran L, Murphy J, Odom L, Stork L, Wei Q, et al. TEL-AMLl fusin identifieds a subset of children with standard fist acute lymphoblastic leukemia who have an excdlent prognosis when treated with therapy that includes a single delayed intensification[J]. Leukemia, 1999, 13(11): 1708-1772.
5. Ramakers-van Woerden NL, Pieters R, Loonen AH, Hubeek I, van Drunen E, Beverloo HB, et al. TEL/AML-l gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia[J]. Blood, 2000, 96(3): 1094-1099.
6. Byrd JC, Dodge RK, Carroll A, Baer MR, Edwards C, Stamberg J, et al. Patients with t(8;21) (q22;q22) and acute myeloid leukemia have superior failure free and over all survival when repetitive cycles of high-dose cytarabine are admin istered[J]. Clin Oncol, 1999, 17(12): 3767-3775.
7. Aricó M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A, et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia[J]. N Engl J Med, 2000, 342(14): 998-1006.
8. Pui CH, Carroll AJ, Raimondi SC, Land VJ, Crist WM, Shuster JJ, et al. Clinical presentation?karyotypic characterization?and treatment outcome of childhood acutelymphoblastic leukemia with a near-haploid or hypodiploid less than45 line[J]. Blood, 1990, 75(5): 1170-1177.
9. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoanq T, Caceres- Cortes J, etal. A cell initiating human acute myeloid leukemia after transplantation into SCID mice[J]. Nature, 1994, 367(6464): 645-648.
10. O'Brien CA, Kreso A, Jamieson CH. Cancer stem cells and self-renewal[J]. Clin Cancer Res, 2010, 16(12): 3113-3120.
11. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells[J]. Nature, 2008, 456(7222): 593-598.
12. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, Johnson TM, et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized[J]. Cancer Cell, 2010, 18(5): 510-512.
13. Seth S, Maier MK, Qiu Q, Ravens I, Kremmer E, Forster R, et al. The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1[J]. Biochem Biophys Res Commun, 2007, 364(4): 959-965.
14. Lock RB, Jin L, Lee EM. CD123 (IL-3 Receptor Chain) neutralization by a monoclonal antibody selectivelyeliminates human acutemyeloid leukemic stem cells [J]. Blood, 2007, 110: 161.
15. Hamann PR, Hinman LM, Hollander I, Beyer CF, Lindh D, Holcomb R, et al. Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia[J]. Bioconjug Chem, 2002, 13(1): 47-58.
16. Fuchs A, Cella M, Giurisato E, Shaw AS, Colonna M. Cutting edge: CD96 (tactile) promotes NK cell target cell adhesion by interacting with the poliovirus receptor (CD155)[J]. J Immunol, 2004, 172(7): 3994-3998.